Literature DB >> 7528818

Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase.

E V Kuzhikandathil1, G R Molloy.   

Abstract

The brain creatine kinase (CKB) gene is expressed in a variety of tissues with highest expression seen in the brain. We have previously shown in primary rat brain cell cultures that CKB mRNA levels are high in oligodendrocytes and astrocytes and low in neurons (Molloy et al.: J Neurochem 59:1925-1932, 1992). In this report we show that treatment of human U87 glioblastoma cells with forskolin and IBMX, to elevate intracellular cAMP, induces expression of CKB mRNA from the transiently transfected rat CKB gene by 14-fold and also increases expression from the endogenous human CKB gene. This induction of CKB mRNA i) is due to increased transcription; ii) occurs rapidly (with maximal induction after 6 hr; iii) requires the activity of protein kinase A (PKA), but iv) does not require de novo protein synthesis and, in fact, is superinduced in the presence of cycloheximide. Given the role of oligodendrocytes in the energy-demanding process of myelination and of astrocytes in ion transport, these results have physiological significance, since they suggest that changes in cellular energy requirements in the brain during events, such as glial cell differentiation and increased neuronal activity, may in part be met by a cAMP-mediated modulation of CKB gene expression. Of particular importance is the possible modulation of CKB gene expression during myelinogenesis, since oligodendrocyte differentiation has been shown previously to be stimulated by increases in cAMP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528818     DOI: 10.1002/jnr.490390110

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Regulation of tail muscle arginine kinase by reversible phosphorylation in an anoxia-tolerant crayfish.

Authors:  Neal J Dawson; Kenneth B Storey
Journal:  J Comp Physiol B       Date:  2011-04-26       Impact factor: 2.200

2.  Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum: evidence for transcriptional regulation.

Authors:  Wei Shen; Dianna Willis; Yanping Zhang; Uwe Schlattner; Theo Wallimann; George R Molloy
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 3.  31P-NMR-measured creatine kinase reaction flux in muscle: a caveat!

Authors:  T Wallimann
Journal:  J Muscle Res Cell Motil       Date:  1996-04       Impact factor: 2.698

Review 4.  Molecular characterization of the creatine kinases and some historical perspectives.

Authors:  W Qin; Z Khuchua; J Cheng; J Boero; R M Payne; A W Strauss
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

Review 5.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

6.  Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.

Authors:  J Zhao; F I Schmieg; D T Simmons; G R Molloy
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

8.  Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Isoform-specific regulation of the Na+/Ca2+ exchanger in rat astrocytes and neurons by PKA.

Authors:  S He; A Ruknudin; L L Bambrick; W J Lederer; D H Schulze
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

10.  Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, 1H and 31P MRS, and clinical and cognitive testing.

Authors:  Melissa Cambron; Tatjana Reynders; Jan Debruyne; Harmen Reyngoudt; Annemie Ribbens; Erik Achten; Guy Laureys
Journal:  J Neurol       Date:  2018-09-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.